## Supplemental Tables. 
### Table1. Summary of serum polyfluorinated chemical concentrations in 357 pregnancy planners, pooled data from PRESTO (2015-2023) and Snart Foraeldre, 2011-2016
| Perfluoroalkyl and polyfluoroalkyl substances (ng/ml) | % Detected | Minimum | 10th pct|25th pct|50th pct|75th pct|90th pct|Maximum|
| :------------- | :------------: | --------------: |---:|---:|---:|---:|---:|---:|
|Perfluorohexane sulfonate (PFHxS)|	98.9|	0.07|	0.2|	0.3|	0.6|	1.1|	2.1|	10.4|
|Perfluorononanoate (PFNA)|	95.2|	0.07|	0.2|	0.2|	0.5|	0.7|	1.0|	3.0|
|Perfluorooctane sulfonate (PFOS)|	99.7|	0.14|	1.1|	1.8|	3.0|	5.6|	8.1|	18.1|
|Perfluorooctanoate (PFOA)|	99.7|	0.14|	0.5|	0.9|	1.4|	2.1|	3.3|	11.8|
|Perfluorodecanoate (PFDeA)|	74.2|	0.07|	0.07|	0.07|	0.2|	0.3|	0.4|	0.9|

### Table 2. Summary of serum polyfluorinated chemical concentrations in 272 PRESTO participants (2015-2023)
| Perfluoroalkyl and polyfluoroalkyl substances (ng/ml) | % Detected | Minimum | 10th pct|25th pct|50th pct|75th pct|90th pct|Maximum|
| :------------- | :------------: | --------------: |---:|---:|---:|---:|---:|---:|
|Perfluorohexane sulfonate (PFHxS)	|98.5	|0.07	|0.3	|0.4	|0.8	|1.3	|2.5	|10.4|
|Perfluorononanoate (PFNA)	|93.8	|0.07	|0.1	|0.2	|0.4	|0.7	|1.1	|3.0|
|Perfluorooctane sulfonate (PFOS)	|99.6	|0.14	|1.0	|1.5	|2.5	|4.4	|7.1	|18.1|
|Perfluorooctanoate (PFOA)econcPFOA	|99.6	|0.14	|0.5	|0.8	|1.3	|2.1	|3.4	|11.8|
|Perfluorodecanoate (PFDeA)	|66.5	|0.07	|0.07	|0.07	|0.1	|0.2	|0.4	|0.9|

### Table 3. Summary of serum polyfluorinated chemical concentrations in 85 Snart Foraeldre participants (2011-2016)
| Perfluoroalkyl and polyfluoroalkyl substances (ng/ml) | % Detected | Minimum | 10th pct|25th pct|50th pct|75th pct|90th pct|Maximum|
| :------------- | :------------: | --------------: |---:|---:|---:|---:|---:|---:|
|Perfluorohexane sulfonate (PFHxS)	|100|0.1	|0.2	|0.2	|0.3	|0.4	|0.5	|1.2|
|Perfluorononanoate (PFNA)	|100|0.2	|0.3	|0.4	|0.6	|0.7	|1.0	|1.5|
|Perfluorooctane sulfonate (PFOS)	|100|0.7	|2.6	|4.2	|5.7	|7.4	|9.3	|16.3|
|Perfluorooctanoate (PFOA)econcPFOA	|100|0.2	|0.7	|1.0	|1.6	|2.1	|3.0	|11.5|
|Perfluorodecanoate (PFDeA)	|98.8|0.07	|0.2	|0.2	|0.3	|0.3	|0.5	|0.6|

### Table 4. Distribution of AMH concentration overall and by cohort in 357 pregnancy planners
|  | Minimum | 10th pct|25th pct|50th pct|75th pct|90th pct|Maximum|
|:---|---:|---:|---:|---:|---:|---:|---:|
|Overall|0.0|	1.4|	2.4|	4.5|	7.9|	11.7|	23.4|
|PRESTO|0.0| 1.4| 2.2| 4.0| 7.2| 11.0| 23.4 |
|Snart Foraeldre|0.1| 1.7| 2.9| 6.0| 9.1| 12.6| 18.4 |
